Show simple item record

dc.contributor.advisorSapsford-Medintz, Kim Een_US
dc.contributor.advisorWhite, Ianen_US
dc.contributor.authorSpindel, Samanthaen_US
dc.date.accessioned2014-06-26T05:34:28Z
dc.date.available2014-06-26T05:34:28Z
dc.date.issued2014en_US
dc.identifier.urihttp://hdl.handle.net/1903/15444
dc.description.abstractThis work investigated optical sensor platforms for protein multiplexing, the ability to analyze multiple analytes simultaneously. Multiplexing is becoming increasingly important for clinical needs because disease and therapeutic response often involve the interplay between a variety of complex biological networks involving multiple, rather than single, proteins. Moreover, one biomarker may be indicative of more than one disease, similar diseases can manifest with similar physical symptoms, and monitoring a disease requires the ability to detect subtle differences over time. Multiplexing is generally achieved through one of two routes, either through spatial separation on a surface (different wells or spots) or with the use of unique identifiers/labels (such as spectral separation - different colored dyes, or unique beads - size or color). We looked into combining both spatial separation and unique labels to further expand the multiplexing capabilities of surfaces. Our original research resulted in one of the few demonstrations of reactive semiconductor nanocrystal immunoassays for multiplexed analysis within a single well on a microtiter plate. Innovative planar surface fluorescent immunoassays were developed for both spatial and spectral multiplexing using Quantum Dots and prospective incorporation into a Point-of-Care (POC) device involving an evanescent wave scanner. These assays used standard microscope slides combined with flow cells and were designed to markedly reduce the amount of sample and reagents needed as compared to standard 96-well plate assays. The platform was optimized for detecting Chicken IgG and Staphylococcal Enterotoxin B (SEB); SEB is commonly used in the literature to characterize the performance of biosensor platforms. The planar surface fluorescent immunoassays were applied to a real-world public health need to detect renal injury. Two emerging novel biomarkers, Kidney Injury Marker-1 (KIM-1) and Neutrophil Gelatinase Associated Lipocalin (NGAL), were investigated for their potential to detect injury earlier and with more specificity than current methods using serum creatinine (SCr). Detecting these medically-relevant markers using planar surface fluorescence immunoassays could potentially allow for more rapid diagnosis of acute kidney injury (AKI), among other uses.en_US
dc.language.isoenen_US
dc.titleEvaluation of Optical Sensor Platforms for Multiplexed Detection of Proteinsen_US
dc.typeDissertationen_US
dc.contributor.publisherDigital Repository at the University of Marylanden_US
dc.contributor.publisherUniversity of Maryland (College Park, Md.)en_US
dc.contributor.departmentBioengineeringen_US
dc.subject.pqcontrolledBiomedical engineeringen_US
dc.subject.pqcontrolledBiochemistryen_US
dc.subject.pqcontrolledEngineeringen_US
dc.subject.pquncontrolledELISAen_US
dc.subject.pquncontrolledFluorescenten_US
dc.subject.pquncontrolledImmunoassayen_US
dc.subject.pquncontrolledMultiplexen_US
dc.subject.pquncontrolledProteinen_US
dc.subject.pquncontrolledQuantum Doten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record